As President of the International Union of Phlebology, it is my great pleasure to invite you to the 2019 UIP Chapter Meeting in Krakow. Having visited this city for a congress in the past, I can certify that Krakow is a wonderful European city with a fascinating history dating back to the 10th century and earlier. A wide variety of easily-accessible and historically significant sites are in close proximity. Viagra Super Active; When Regular Cialis 20mg Just Isn't Enough.
I can assure you of a meeting of the highest scientific quality, with equally exciting social functions. I look forward to seeing everyone there at this highly anticipated UIP Chapter Meeting. Please put it on your calendar and don't miss it. Tutte le cose che volevate sapere su Kamagra oral jelly 100mg ma che avevate paura di chiedere.
It is our great pleasure to invite You to the International Union of Phlebology Meeting, being held in Krakow in Poland from 25th to 27th August 2019. The meeting in the historical city of Krakow will be entirely dedicated to various aspects of the modern phlebology. The venue of the Meeting will be an ICE Krakow Congress Centre located very near to the historical Wawel Castle and Old Town. Edschweiz.com - Kamagra Oral Jelly: Für Menschen, die keine Tabletten einnehmen möchten.
By inviting You to Krakow, I hope You will be an active part of this important international event. We also encourage You to be the part of the scientific program as well as to present and share Your experience in the vein disease diagnostics, treatment and basic science research. We hope that for many Phlebologists from Europe and other Continents, the Meeting will be a great opportunity to gain experience and knowledge from the Expert Speakers coming to Krakow from many countries and Phlebological Societies. On behalf of the International Union of Phlebology as well as The Polish Society of Phlebology we hope You will have an enjoyable and interesting experience throughout the UIP Krakow Meeting, as well as a pleasant stay in the unique atmosphere of the beautiful city Krakow. Priligy 30mg er den nyeste og mest pålitelige løsningen som vil stoppe erektil dysfunksjon og gjenopprette selvtilliten din
Yours sincerely,
on behalf of the Local Organizers
Tomasz Urbanek
Polish Society of Phlebology
By inviting You to Krakow, I hope You will be an active part of this important international event. We also encourage You to be the part of the scientific program as well as to present and share Your experience in the vein disease diagnostics, treatment and basic science research. We hope that for many Phlebologists from Europe and other Continents, the Meeting will be a great opportunity to gain experience and knowledge from the Expert Speakers coming to Krakow from many countries and Phlebological Societies. On behalf of the International Union of Phlebology as well as The Polish Society of Phlebology we hope You will have an enjoyable and interesting experience throughout the UIP Krakow Meeting, as well as a pleasant stay in the unique atmosphere of the beautiful city Krakow. Priligy 30mg er den nyeste og mest pålitelige løsningen som vil stoppe erektil dysfunksjon og gjenopprette selvtilliten din
Yours sincerely,
on behalf of the Local Organizers
Tomasz Urbanek
Polish Society of Phlebology
Preliminary detailed program
Download Program
8.00 - 9.30
UIP SESSION I 
Chairs: Nick Morrison, Kurosh Parsi
Co-moderators: Nick Morrison (President), Kurosh Parsi (President-elect), Andrew Bradbury (Chair, Scientific Committee), Mark Meissner (General Secretary), Oscar Bottini (Chair, Education Committee), David Connor (Executive Director), Lowell Kabnick (Vice President), Victor Canata (Vice President), Sergio Gianesini (Vice President), Lorenzo Tessari (Vice President), Dong-ik Kim (Vice President), Malay Patel (Assistant Secretary)
Chairs: Nick Morrison, Kurosh Parsi
Co-moderators: Nick Morrison (President), Kurosh Parsi (President-elect), Andrew Bradbury (Chair, Scientific Committee), Mark Meissner (General Secretary), Oscar Bottini (Chair, Education Committee), David Connor (Executive Director), Lowell Kabnick (Vice President), Victor Canata (Vice President), Sergio Gianesini (Vice President), Lorenzo Tessari (Vice President), Dong-ik Kim (Vice President), Malay Patel (Assistant Secretary)
8.00 - 8.10
Nick Morrison
Presidential lecture
Presidential lecture
8.10 - 8.20
Kurosh Parsi
UIP Future: Our Vision and Mission
UIP Future: Our Vision and Mission
8.20 - 8.30
Andrew Bradbury
UIP Scientific Committee. Major Scientific Findings in Phlebology in the Past 2 Years
UIP Scientific Committee. Major Scientific Findings in Phlebology in the Past 2 Years
8.30 - 8.40
Mark Meissner
Post-thrombotic Syndrome: Need for a New Instrument
Post-thrombotic Syndrome: Need for a New Instrument
8.40 - 8.45
Mark Meissner
UIP Operations: Need for Reform
UIP Operations: Need for Reform
8.45 - 8.55
Oscar Bottini
UIP Education Program: Our exciting new initiatives
UIP Education Program: Our exciting new initiatives
8.55 - 9.00
David Connor
UIP Educational Modules
UIP Educational Modules
9.00 - 9.20
UIP Vice Presidents: Lowell Kabnick, Victor Canata, Sergio Gianesini, Lorenzo Tessari,Dong-ik Kim
Around the Globe with UIP: North America, Latin America, Northern Europe, Near East, North Africa, Southern Europe, Asia and Oceania
Around the Globe with UIP: North America, Latin America, Northern Europe, Near East, North Africa, Southern Europe, Asia and Oceania
9.20 - 9.30
Discussion
9.35 - 09.55
KEYNOTE LECTURE: Mark Meissner
Chronic pelvic vein disease 2019 update: what do we know? what we do not know?
Chronic pelvic vein disease 2019 update: what do we know? what we do not know?
10.00 - 10.30
Coffee break
10.30 - 12.00
SCIENTIFIC SESSION:
Foam Sclerotherapy – from the consensus document to the clinical practice
Chair: E. Rabe
Co-moderators: L. Tessari, A. Bradbury, C. Hamel-Desnos, N. Morrison, K. Parsi, Z. Rybak
Foam Sclerotherapy – from the consensus document to the clinical practice
Chair: E. Rabe
Co-moderators: L. Tessari, A. Bradbury, C. Hamel-Desnos, N. Morrison, K. Parsi, Z. Rybak
10.30 - 10.40
Eberhard Rabe
New European Guidelines on Sclerotherapy – what is new?
New European Guidelines on Sclerotherapy – what is new?
10.40 - 10.55
Andrew Bradbury
Tips and tricks of successfully maintaining and injecting foam – what should we know about US guided foam sclerotherapy?
Tips and tricks of successfully maintaining and injecting foam – what should we know about US guided foam sclerotherapy?
10.55 - 11.05
Lorenzo Tessari
Foam sclerotherapy – the safety issue
Foam sclerotherapy – the safety issue
11.05 - 11.15
Attilio Cavezzi
Saphenous vein sclerotherapy – does tumescence and blood irrigation make the difference?
Saphenous vein sclerotherapy – does tumescence and blood irrigation make the difference?
11.15 - 11.25
Neil Khilnani
Foam Sclerotherapy in C1 treatment
Foam Sclerotherapy in C1 treatment
11.25 - 11.35
Claudine Hamel-Desnos
How sclerothepary can replace phlebectomy in primary therapeutic attempt or in the recurrent varicose vein treatment?
How sclerothepary can replace phlebectomy in primary therapeutic attempt or in the recurrent varicose vein treatment?
11.35 - 11.45
Marianne de Maeseneer
Is atrophie blanche irreversible? Effects of foam sclerotherapy
Is atrophie blanche irreversible? Effects of foam sclerotherapy
11.45 - 11.55
Johann Chris Ragg
Foam sclerotherapy – lessons from physics and chemistry
Foam sclerotherapy – lessons from physics and chemistry
11.55 - 12.00
Session summary: Nick Morrison
Discussion will continue during the LUNCH with the Sclerotherapy Experts – Multi Hall S4 12.00-12.45
Discussion will continue during the LUNCH with the Sclerotherapy Experts – Multi Hall S4 12.00-12.45
12.00 - 13.00
Lunch
13.00 - 14.15
SCIENTIFIC SESSION:
C0s – towards consensus on the diagnostics and therapy
Chair: A. Nicolaides
Co-moderators: E. Rabe, N. Labropoulos, C. Allegra, S. Kakkos, M. Schul , A. Jawień
C0s – towards consensus on the diagnostics and therapy
Chair: A. Nicolaides
Co-moderators: E. Rabe, N. Labropoulos, C. Allegra, S. Kakkos, M. Schul , A. Jawień
13.00 - 13.10
Eberhard Rabe
Epidemiology of C0s – what do we know about?
Epidemiology of C0s – what do we know about?
13.10 - 13.20
Andrew Nicolaides
The link between hemodynamics and signs as well as symptoms of the chronic venous disease
The link between hemodynamics and signs as well as symptoms of the chronic venous disease
13.20 - 13.30
Nicos Labropoulos
Symptoms of the chronic venous disease learning through a clinical casev. How to assess the symptoms of the chronic venous disease – 2019 update?
Symptoms of the chronic venous disease learning through a clinical casev. How to assess the symptoms of the chronic venous disease – 2019 update?
13.30 - 13.40
Marc Vuylsteke
Chronic venous disease progression – is it unavoidable?
Chronic venous disease progression – is it unavoidable?
13.40 - 13.50
Patrick Carpentier
C0s diagnostics – objective evaluation and possibilities of confirmation of the chronic disease presence in C0s patients
C0s diagnostics – objective evaluation and possibilities of confirmation of the chronic disease presence in C0s patients
13.50 - 14.00
Stavros Kakkos
C0s treatment possibilities – 2019 update
C0s treatment possibilities – 2019 update
14.00 - 14.15
Discussion
14.15 - 15.30
SCIENTIFIC SESSION:
Innovations in phlebology
Chair: S. Elias
Co-moderators: R. Milleret, Ch. Ragg, W. Chi, T. Yamaki, E. Shaydakov, G. Halena
Innovations in phlebology
Chair: S. Elias
Co-moderators: R. Milleret, Ch. Ragg, W. Chi, T. Yamaki, E. Shaydakov, G. Halena
14.15 - 14.25
Steve Elias
Fully percutaneously created or surgically inserted artificial vein valves in CVD treatment – research status and first clinical data
Fully percutaneously created or surgically inserted artificial vein valves in CVD treatment – research status and first clinical data
14.25 - 14.35
Stephen Black
Recent developments in the dedicated venous stents – lessons learned and future direction
Recent developments in the dedicated venous stents – lessons learned and future direction
14.35 - 14.45
Johann Chris Ragg
Hyaluronan injection based treatment in phlebology – why and when?
Hyaluronan injection based treatment in phlebology – why and when?
14.45 - 14.55
Alfred Obermayer
First percutaneous – non invasive – vein ablations using high intensity focused ultrasound (HIFU)
First percutaneous – non invasive – vein ablations using high intensity focused ultrasound (HIFU)
14.55 - 15.05
Rene Milleret, B. Greillier, O. Pichot, T. Charrel, C. Lafon
Transcutaneous obliteration of varicose veins by ultrasound: HIFU and Cavitation solutions
Transcutaneous obliteration of varicose veins by ultrasound: HIFU and Cavitation solutions
15.05 - 15.15
Willy Chi
Telemetric vein diagnostics: how does technology enable patients compliance?
Telemetric vein diagnostics: how does technology enable patients compliance?
15.15 - 15.25
Francesco Zini
SFALT: Sclerofoam assisted laser therapy for saphenous refluxes: an innovative tumescence-free technique
SFALT: Sclerofoam assisted laser therapy for saphenous refluxes: an innovative tumescence-free technique
15.25 - 15.30
Session summary: Steve Elias
Discussion with the Innovators – Exhibition Area/Discussion Corner
Discussion with the Innovators – Exhibition Area/Discussion Corner
15.30 - 16.00
Coffee break
16.00 - 17.35
SCIENTIFIC SESSION:
What is new in our understanding of the chronic venous disease
Chair: A. Nicolaides
Co-moderators: N. Morrison, C. Allegra, P. Thibault, Ch. Lattimer, T. Zubilewcz, S. Kakkos
What is new in our understanding of the chronic venous disease
Chair: A. Nicolaides
Co-moderators: N. Morrison, C. Allegra, P. Thibault, Ch. Lattimer, T. Zubilewcz, S. Kakkos
16.00 - 16.10
Christopher Lattimer
Our current understanding of the chronic venous obstruction
Our current understanding of the chronic venous obstruction
16.10 - 16.20
Nicos Labropoulos
Chronic venous thrombosis – does it really exsist
Chronic venous thrombosis – does it really exsist
16.20 - 16.30
Marian Simka
What is new in our understanding of the cerebral venous outflow? – possible link with neurodegeneration
What is new in our understanding of the cerebral venous outflow? – possible link with neurodegeneration
16.30 - 16.40
Paul Thibault
Neck vein obstruction: Diagnosis and the role of chronic Chlamydophila pneumoniae infection
Neck vein obstruction: Diagnosis and the role of chronic Chlamydophila pneumoniae infection
16.40 - 16.50
Johann Chris Ragg
Every valve tells a story! what do we know from HR Ultrasound research on the valve impact on the CVD occurrence and progression – clinical implications
Every valve tells a story! what do we know from HR Ultrasound research on the valve impact on the CVD occurrence and progression – clinical implications
16.50 - 17.00
Sarah Onida
Venous diameter, clinical severity and quality of life – does the size of the incompetent vein matters?
Venous diameter, clinical severity and quality of life – does the size of the incompetent vein matters?
17.00 - 17.10
Ferdinando Mannello, Daniela Ligi, Rosanna Maniscalco, Leonardo Aluigi, Pier Luigi Antignani
What is new in our understanding of the chronic venous disease pathogenesis at the cell and tissue level
What is new in our understanding of the chronic venous disease pathogenesis at the cell and tissue level
17.10 - 17.20
Gabriele Färber
Obesity and Inflammation in venous and lymphatic diseases
Obesity and Inflammation in venous and lymphatic diseases
17.20 - 17.25
Sergio Gianesini
Guidelines from the world: 5 minutes for 5 emergent recommendations
Guidelines from the world: 5 minutes for 5 emergent recommendations
17.25 - 17.35
Discussion
Session Summary: Andrew Nicolaides
Session Summary: Andrew Nicolaides
8.00 - 12.00
Plenary Room only, please see the program
12.00 - 13.00
Lunch
13.00 - 15.20
SCIENTIFIC SESSION:
VTE session /I/ 2019 treatment update
Chair: P. Prandoni
Co-moderators: J. Fareed, PL. Antignani, L. Chernuka, G. Palareti, Z. Krasiński
VTE session /I/ 2019 treatment update
Chair: P. Prandoni
Co-moderators: J. Fareed, PL. Antignani, L. Chernuka, G. Palareti, Z. Krasiński
13.00 - 13.15
Paolo Prandoni
The novel anticoagulants for the initial and long-term treatment of VTE: state of the art
The novel anticoagulants for the initial and long-term treatment of VTE: state of the art
13.15 - 13.25
Wojciech Sydor
Patient oriented anticoagulation in VTE treatment: – efficacy and safety of the new and old therapeutic approach – are the DOACs standard of care?
Patient oriented anticoagulation in VTE treatment: – efficacy and safety of the new and old therapeutic approach – are the DOACs standard of care?
13.25 - 13.35
Larisa Chernukha
Cancer related DVT – what is new in the prevention and treatment?
Cancer related DVT – what is new in the prevention and treatment?
13.35 - 13.45
Niels Baekgaard
Open vein concept in acute DVT treatment – still valid approach or already the past?!
Open vein concept in acute DVT treatment – still valid approach or already the past?!
13.45 - 13.55
Gualtiero Palareti
Unmet needs in VTE clinical management
Unmet needs in VTE clinical management
13:55 - 14.05
Zbigniew Krasiński
Venous problems in thoracic outlet syndrome: thrombolysis, anticoagulation, rib resection: staged or simultaneous?
Venous problems in thoracic outlet syndrome: thrombolysis, anticoagulation, rib resection: staged or simultaneous?
14.05 - 14.15
Hot topics in anticoagulation
Jeanine Walenga
Optimization of anticoagulation with DOACs: role of proper selection and assessment
Jeanine Walenga
Optimization of anticoagulation with DOACs: role of proper selection and assessment
14.15 - 14.25
Hot topics in anticoagulation
Jawed Fareed
An update on the development of antidotes for NOACs
Jawed Fareed
An update on the development of antidotes for NOACs
14.25 - 14.35
Hot topics in anticoagulation
Willy Chi
Superficial vein thrombosis – Controversies in superficial venous thrombosis epidemiology and management
Willy Chi
Superficial vein thrombosis – Controversies in superficial venous thrombosis epidemiology and management
14.35 - 14.45
Hot topics in anticoagulation
Isaac K Nyamekye
Anti-DVT prophylaxis in patients undergoing thermal endovenous varicose vein treatment
Isaac K Nyamekye
Anti-DVT prophylaxis in patients undergoing thermal endovenous varicose vein treatment
14.45 - 14.55
Hot topics in anticoagulation
Jaroslav Strejček
New look at endovenous heat-induced thrombosis risk assessment after endovenous venous thermal procedures
Jaroslav Strejček
New look at endovenous heat-induced thrombosis risk assessment after endovenous venous thermal procedures
14.55 - 15.20
Discussion
15.20 - 15.50
Coffee break
15.50 - 18.00
SCIENTIFIC SESSION:
Compression treatment solutions in vein and lymphatic diseases
Chair: G. Mosti
Co-moderators: H. Partsch, E. Rabe, G M. Malouf, P. Carpentier, M. Danese, T. Drążkiewicz
Compression treatment solutions in vein and lymphatic diseases
Chair: G. Mosti
Co-moderators: H. Partsch, E. Rabe, G M. Malouf, P. Carpentier, M. Danese, T. Drążkiewicz
15.50 - 16.00
Eberhard Rabe
Current indications and guidelines for medical compression stockings
Current indications and guidelines for medical compression stockings
16.00 - 16.10
Giovanni Mosti
Elastic and non-elastic compression – how strong should it be to reach the therapeutic goals? Compression solutions in the venous leg ulcer patients
Elastic and non-elastic compression – how strong should it be to reach the therapeutic goals? Compression solutions in the venous leg ulcer patients
16.10 - 16.20
Willy Chi
Interface pressure measurement: why and how?
Interface pressure measurement: why and how?
16.20 - 16.30
Franz Josef Schingale
Compression for lymphedema patients – which one is the best? when and how?
Compression for lymphedema patients – which one is the best? when and how?
16.30 - 16.40
Aleksandra Jaworucka-Kaczorowska
Graduated compression in obgyn patients
Graduated compression in obgyn patients
16.40 - 16.50
Francisco Reis Bastos
Compression after venous procedures
Compression after venous procedures
16.50 - 16.57
Attilio Cavezzi
Evidence based compression with Velcro device
Evidence based compression with Velcro device
16.57 - 17.04
Johann Chris Ragg
Update on film compression
Update on film compression
17.04 - 17.11
Sergio Gianesini
Compression called water: aquatic protocols for phlebo-lymphedema patients
Compression called water: aquatic protocols for phlebo-lymphedema patients
17.11 - 17.21
Alberto Caggiati on behalf of the Underwater Compression Group: Kontothanassis D., Oberto S., Bissacco D., Lattimer C., Caggiati A.
Underwater investigation of leg veins morphology and flow
Underwater investigation of leg veins morphology and flow
17.21 - 17.31
Giovanni Mosti
News in medical compression and what’s on the horizon?
News in medical compression and what’s on the horizon?
17.31 - 17.41
Malay Patel
Early detection of Chronic Venous Disease and treatment algorithm in developing countries – is there space for compression?
Early detection of Chronic Venous Disease and treatment algorithm in developing countries – is there space for compression?
17.41 - 18.05
Discussion
8.00 - 12.00
Plenary Room only, please see the program
12.00 - 12.30
Lunch
12.30 - 13.50
SCIENTIFIC SESSION:
Varicose vein treatment – limitations and solutions
Chair: R. Simkin
Co-moderators: Dong-ik Kim, A. Cavezzi, A. Frullini , I. Nyamekye, I. Zolotukhin, A. Jaworucka -Kaczorowska
Varicose vein treatment – limitations and solutions
Chair: R. Simkin
Co-moderators: Dong-ik Kim, A. Cavezzi, A. Frullini , I. Nyamekye, I. Zolotukhin, A. Jaworucka -Kaczorowska
12.30 - 12.40
Ravul Jindal
Should we be worried about Gastrocnemius muscle veins?
Should we be worried about Gastrocnemius muscle veins?
12.40 - 12.50
Dong-ik Kim
Venous hemodynamics in varicose vein surgery
Venous hemodynamics in varicose vein surgery
12.50 - 13.00
Alessandro Frullini
The false miths of sclerotherapy
The false miths of sclerotherapy
13.00 - 13.10
Enrico Cappello
Excluded saphenous vein technique – ESVT
Excluded saphenous vein technique – ESVT
13.10 - 13.20
Solange Evangelista
Microfoam Sclerotherapy in Recurrent Varicose Veins Following Surgery
Microfoam Sclerotherapy in Recurrent Varicose Veins Following Surgery
13.20 - 13.30
Isaac K Nyamekye
The 3RF Study: Randomised Trial of 3 Radiofrequency Devices for Great Saphenous Vein Ablation: Comparison of Venefit, RFITT and EVRF Devices
The 3RF Study: Randomised Trial of 3 Radiofrequency Devices for Great Saphenous Vein Ablation: Comparison of Venefit, RFITT and EVRF Devices
13.30 - 13.40
Roberto Simkin
Difficult situations in Phlebology, treatment and solutions
Difficult situations in Phlebology, treatment and solutions
13.40 - 13.50
Discussion
13.50 - 15.20
SCIENTIFIC SESSION:
Latin America Session I
Chair: V. Canata, O. Bottini
Co-moderators: A. Scuderi, R. Simkin, A. Martinez Granados, E. Intriago, J. Serralde Gallegos, O. Regalado, N. Rosli
Latin America Session I
Chair: V. Canata, O. Bottini
Co-moderators: A. Scuderi, R. Simkin, A. Martinez Granados, E. Intriago, J. Serralde Gallegos, O. Regalado, N. Rosli
13.50 - 13.56
Juan Nigro
Treatment of remainder or recurrent vein post embolization in pelvic congestion syndrome with echo sclerosis
Treatment of remainder or recurrent vein post embolization in pelvic congestion syndrome with echo sclerosis
13.56 - 14.00
Discussant: Javier Leal Monedero
14.00 - 14.06
Francisco Reis Bastos
Sclerotherapy with FOAM, analysis after 15 years. Extrinsic compression after venous procedures
Sclerotherapy with FOAM, analysis after 15 years. Extrinsic compression after venous procedures
14.06 - 14.10
Discussant: Ernesto Intriago (junior)
14.10 - 14.16
Jorge Correa
Treatment of hemorrhoids with sclerotherapy. Myths and truths
Treatment of hemorrhoids with sclerotherapy. Myths and truths
14.16 - 14.20
Discussant: Solange Evangelista
14.20 - 14.26
Carlos Carvalho
Cryo sclerotherapy. 17 years of experience
Cryo sclerotherapy. 17 years of experience
14.26 - 14.30
Discussant: Alberto Martinez Granados
14.30 - 14.36
Juan Manuel López Chavez
Ultrasonographic vasospasm as a reliable parameter of success in eco-guided sclerotherapy
Ultrasonographic vasospasm as a reliable parameter of success in eco-guided sclerotherapy
14.36 - 14.40
Discussant: Mabel Bussati
14.40 - 14.46
Juan Manuel Piegas Areta
Sclerosis in surgical recurrence
Sclerosis in surgical recurrence
14.46 - 14.50
Discussant: Never Rosli
14.50 - 14.56
Daiane Albernaz
CEAP C1-2 Quality of life Study
CEAP C1-2 Quality of life Study
14.56 - 15.00
Discussant: Graciela Figueiredo Rodriguez
15.00 - 15.06
Roberto Simkin
The global managmet of the Klipppel Trenaunay Syndrome
The global managmet of the Klipppel Trenaunay Syndrome
15.06 - 15.10
Discussant: Juan Carlos Patt
15.10 - 15.20
Discussion
15.20 - 15.30
Coffee break
15.30 - 18.05
